Teleophthalmology-enabled and artificial intelligence-ready referral pathway for community optometry referrals of retinal disease (HERMES): a Cluster Randomised Superiority Trial with a linked Diagnostic Accuracy Study—HERMES study report 1—study protocol

Author:

Han Ji Eun DianaORCID,Liu XiaoxuanORCID,Bunce CateyORCID,Douiri Abdel,Vale Luke,Blandford AnnORCID,Lawrenson John,Hussain Rima,Grimaldi Gabriela,Learoyd Annastazia EORCID,Kernohan Ashleigh,Dinah Christiana,Minos Evangelos,Sim Dawn,Aslam Tariq,Patel Praveen J,Denniston Alastair K,Keane Pearse A,Balaskas Konstantinos

Abstract

IntroductionRecent years have witnessed an upsurge of demand in eye care services in the UK. With a large proportion of patients referred to Hospital Eye Services (HES) for diagnostics and disease management, the referral process results in unnecessary referrals from erroneous diagnoses and delays in access to appropriate treatment. A potential solution is a teleophthalmology digital referral pathway linking community optometry and HES.Methods and analysisThe HERMES study (Teleophthalmology-enabled and artificial intelligence-ready referral pathway for community optometry referrals of retinal disease: a cluster randomised superiority trial with a linked diagnostic accuracy study) is a cluster randomised clinical trial for evaluating the effectiveness of a teleophthalmology referral pathway between community optometry and HES for retinal diseases. Nested within HERMES is a diagnostic accuracy study, which assesses the accuracy of an artificial intelligence (AI) decision support system (DSS) for automated diagnosis and referral recommendation. A postimplementation, observational substudy, a within-trial economic evaluation and discrete choice experiment will assess the feasibility of implementation of both digital technologies within a real-life setting. Patients with a suspicion of retinal disease, undergoing eye examination and optical coherence tomography (OCT) scans, will be recruited across 24 optometry practices in the UK. Optometry practices will be randomised to standard care or teleophthalmology. The primary outcome is the proportion of false-positive referrals (unnecessary HES visits) in the current referral pathway compared with the teleophthalmology referral pathway. OCT scans will be interpreted by the AI DSS, which provides a diagnosis and referral decision and the primary outcome for the AI diagnostic study is diagnostic accuracy of the referral decision made by the Moorfields-DeepMind AI system. Secondary outcomes relate to inappropriate referral rate, cost-effectiveness analyses and human–computer interaction (HCI) analyses.Ethics and disseminationEthical approval was obtained from the London—Bromley Research Ethics Committee (REC 20/LO/1299). Findings will be reported through academic journals in ophthalmology, health services research and HCI.Trial registration numberISRCTN18106677 (protocol V.1.1).

Funder

Health Technology Assessment Programme

Publisher

BMJ

Subject

General Medicine

Reference18 articles.

1. The Royal College of Ophthalmologists . The way forward, 2021. Available: https://www.rcophth.ac.uk/wp-content/uploads/2015/10/RCOphth-The-Way-Forward-Executive-Summary-300117.pdf [Accessed 9 Jun 2021].

2. NHS Digital . Hospital outpatient activity 2019-20: main specialty, 2020. Available: https://digital.nhs.uk/data-and-information/publications/statistical/hospital-outpatient-activity/2019-20 [Accessed 9 Jun 2021].

3. A survey of current and anticipated use of standard and specialist equipment by UK optometrists;Dabasia;Ophthalmic Physiol Opt,2014

4. Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme

5. Clinical safety of a minor eye conditions scheme in England delivered by community optometrists;Konstantakopoulou;BMJ Open Ophthalmol,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3